GlassScriptPhysician profile
Julia M Stoerr
NPI 1265982219
$9,989.62
in general payments reported to CMS, 2019-2025
53 companies · $1,969 in 2025
The $1,969 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,050 · 2022: $1,365 · 2023: $3,681 · 2024: $1,925 · 2025: $1,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,468 · Travel and Lodging: $952 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,468.28 |
| Travel and Lodging | $952.48 |
| Education | $153.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,416.09 | 2023 | Vns Therapy |
| Abbvie INC. | $1,368.17 | 2022-2025 | |
| Sk Life Science, INC. | $1,121.07 | 2021-2025 | Xcopri |
| Jazz Pharmaceuticals INC. | $947.16 | 2022-2025 | |
| Ucb, INC. | $803.55 | 2021-2025 | Nayzilam, Fintepla, Briviact |
| Collegium Pharmaceutical, INC. | $663.72 | 2023-2025 | Xtampza, Belbuca |
| Teva Pharmaceuticals USA, INC. | $219.21 | 2021-2024 | Austedo Xr, Ajovy |
| Neurocrine Biosciences, INC. | $201.45 | 2023-2025 | Ingrezza, Ongentys |
| Biohaven Pharmaceuticals, INC. | $199.67 | 2021 | |
| Harmony Biosciences LLC | $186.18 | 2022-2025 | Wakix |
| Neurelis, INC. | $184.40 | 2022-2024 | Valtoco |
| Lundbeck LLC | $181.61 | 2021-2025 | Vyepti, Rexulti |
| Axsome Therapeutics, INC. | $177.13 | 2023-2025 | Sunosi, Symbravo |
| Amgen INC. | $167.41 | 2021-2023 | Aimovig |
| Pfizer INC. | $160.69 | 2023-2025 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Stoerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.